BRIEF published on 10/31/2025 at 18:09, 3 months 20 days ago Euromedis Laboratories - 2025 Half-Year Financial Results Revenue Net Result Cost Optimization Export Sales Social Movements
BRIEF published on 10/31/2025 at 18:09, 3 months 20 days ago Laboratoires Euromedis - Résultats financiers semestriels 2025 Chiffre D'affaires Résultat Net Optimisation Des Coûts Mouvements Sociaux Ventes À L'export
REGULATED PRESS RELEASE published on 10/31/2025 at 18:04, 3 months 20 days ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2025 SA Laboratoires Euromedis publie son rapport financier semestriel au 30 juin 2025, montrant une progression du chiffre d'affaires de 11% et un retour au positif du résultat net Chiffre D'affaires Rapport Financier Résultat Net SA Laboratoires Euromedis 30 Juin 2025
REGULATED PRESS RELEASE published on 04/29/2025 at 19:13, 9 months 20 days ago Rapport Financier Annuel - 31/12/2024
BRIEF published on 04/25/2025 at 18:05, 9 months 25 days ago Euromedis Group: 2024 Annual Results Turnover Judicial Liquidation Geopolitical Tensions Euromedis Group 2024 Results
BRIEF published on 04/25/2025 at 18:05, 9 months 25 days ago Euromedis Groupe : Résultats annuels 2024 Chiffre D'affaires Résultats 2024 Liquidation Judiciaire Tensions Géopolitiques Euromedis Groupe
REGULATED PRESS RELEASE published on 04/25/2025 at 18:00, 9 months 25 days ago Euromedis - Communiqué résultat 2024 Le Conseil d’Administration annonce les résultats annuels 2024 avec une hausse de 6% du chiffre d'affaires malgré des défis. Des perspectives de croissance et d'économie pour 2025 Croissance Économie Résultats Annuels 2024 Perspectives 2025 Défis
BRIEF published on 12/10/2024 at 16:40, 1 year 2 months ago Euromedis Laboratories: Adjustment of the liquidity contract Liquidity Securities AMF Regulation Euromedis
BRIEF published on 12/10/2024 at 16:40, 1 year 2 months ago Laboratoires Euromedis : Ajustement du contrat de liquidité Liquidité AMF Regulation Titres Euromedis
REGULATED PRESS RELEASE published on 12/10/2024 at 16:35, 1 year 2 months ago LABORATOIRES EUROMEDIS - Ajustement du contrat de liquidité Modification du contrat de liquidité entre LABORATOIRES EUROMEDIS et la Société de Bourse Gilbert Dupont pour se conformer à la décision AMF n° 2018-01 du 2 juillet 2018. Retrait de 8 000 titres le 13 décembre 2024 Société De Bourse Gilbert Dupont Contrat De Liquidité AMF Laboratoires Euromedis Retrait
Published on 02/20/2026 at 18:30, 24 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 9 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 24 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 46 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 54 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 17 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 54 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 54 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 26 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 26 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
